ZOBELE HOLDING SPA

ZOBELE HOLDING SPA has been granted 126 US utility patents between 2015 and 2025, placing ZOBELE HOLDING SPA at rank #3,030 across all assignees tracked by PlainPatent. This portfolio spans 23 distinct Cooperative Patent Classification (CPC) subclasses, averaging 4.9 claims per patent with primary concentration in A61L (METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES;). As a Foreign Corporation, ZOBELE HOLDING SPA is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 39.9/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 77 grants, compared with 49 in the 2015–2019 window — a +57% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. ZOBELE HOLDING SPA's 4.9 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while a multi-domain presence across 23 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark ZOBELE HOLDING SPA against peers pursuing similar technology classes.